Neurobehavioral teratogenicity of perfluorinated alkyls in an avian model☆
Introduction
Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) are prominent members of the family of perfluorinated alkyls (PFAs). These compounds are widely used for manufacturing non-stick coatings and stain repellents in fabrics, as well as in food-packaging and lubricants. PFAs are very poorly biodegradable and are accumulating in humans and ecosystems worldwide [17], extending even to animals in remote locations [10]. Thus, despite recent efforts to reduce or phase out PFA production [9], these agents will persist in the environment [20], [26].
Parallel to PFA bioaccumulation, toxicological studies in adult rats given high doses have shown damage to several internal organs, including the liver, kidneys and heart [43], preceded by substantial pathological changes in gene expression patterns [12]; parallel findings have been reported in zebra fish [29] and chicks [42]. In developing rodents, prenatal exposure to perfluorooctane sulfonate (PFOS) compromises survival rates and delays general growth and development [35]. In chicks, prenatal exposure to PFOS or perfluorooctanoic acid (PFOA) elicits reductions in hatchability, interference with pigmentation and pathological changes in the liver [24], [38]. In our earlier work, we pointed out that the biochemical characteristics that underlie plumage pigmentation in the chick are also critical for nervous system development [38], suggesting that the PFAs might be developmental neurotoxicants, a prediction we confirmed with in vitro models of neuronal development [30].
Studies in rodents similarly point to behavioral deficits in adulthood after neonatal exposure to PFOA or PFOS [16], reflecting an adverse impact on functioning of critical neurochemical events required for synaptic development and function [15]. Nevertheless, rodent models have inherent methodological shortcomings from confounding maternal factors, notably maternal care and mother–offspring interaction [27], [32], and the so-called “litter effect,” [33], where animals within a given litter are not independent of each other. Obviously, in the chick model, these limitations do not apply, since there is no maternal interaction and every individual represents an independent sample; further, because the chick is more mature at hatching than are newborn rats or mice, cognitive behavior, in the form of imprinting performance, can be evaluated immediately, prior to any potential impact of prenatal treatment on feeding or other indirect contributors to behavioral abnormalities. A newborn chick tends to follow the first object it sees after hatching [21] and can thus be imprinted upon an artificial object, which then becomes a suitable subject for studying the effect of prenatal treatments on imprinting behavior [5], [8], [31]. We have already demonstrated how this parallels hippocampus-related visuospatial cognitive performance in rodents [39], involving in the chick the left intermedial part of the hyperstriatum ventrale (IMHV) [5], [13]; specifically, cholinergic innervation in the left IMHV controls the chicks' perception of the imprinting stimulus [22], [36]. Given the postulated involvement of cholinergic deficits in the long-term neurobehavioral effects of neonatal PFOA and PFOS exposure in rodents [16], in the present study we evaluated whether these agents have an adverse effect on imprinting performance in the chick model.
In addition to behavioral assessments, we also evaluated the impact of PFOA and PFOS exposure on the concentration of protein kinase C (PKC) isoforms, which play an integral mechanistic role in transducing cholinergic input involved in learning and memory. Specifically, the translocation of PKC from the cytoplasm to the membrane is required for imprinting [3], [4], [25], [37]. In our studies, we obtained the brain samples immediately after the imprinting test so as to examine the ability of the imprinting stimulus to evoke PKC translocation. Indeed, in earlier work with other neurotoxicants known to target cholinergic function, we confirmed the direct relationship between adverse effects on PKC translocation and imprinting performance [14]. Here, we identified different patterns of effects of PFOA and PFOS on PKC-related mechanisms in association with impaired imprinting behavior.
Section snippets
Teratogen treatments
Fertile heterogeneous stock eggs (60 ± 3 g) of the Cobb I chicken broiler strain (Gallus gallus domesticus) were obtained from a commercial source and placed in an incubator. To introduce substances, a hole was drilled in the chorioallantois end (pointed end) of the shell and PFOA and PFOS (Sigma, Israel) were then administered before commencing incubation, i.e. on incubation day 0 (the PFOA in its free acid form and the PFOS in its salt form, due to dilution difficulties). The hole was then
Results
On incubation day 19, fewer of the PFA-exposed eggs contained developing embryos as compared to the control groups, with reductions ranging from 30% to 50% (Fig. 1a). In addition, there were even further reductions in hatchability. However, among the chicks that hatched, there was no difference in weight (Fig. 1b) nor in the scoring for general morphology and function (Fig. 1c).
Control chicks showed typically-high imprinting scores [14] of about 0.8 (Fig. 2a). Chicks exposed to either of the
Discussion
In the present study, embryonic exposure to PFOA and PFOS induced posthatch deficits in imprinting behavior in association with alterations in the concentrations of PKC isoforms within the left IMHV, the brain region in which imprinting is consolidated. Whereas the behavioral deficits were similar for both PFAs the changes at the molecular level differed, although as discussed below, the PKC changes for both agents are consistent with impaired expression and function of these key intermediates.
Conflict of interest
No author has any conflict of interest to disclose.
Acknowledgements
Supported by NIH grant ES014258, the United States–Israel Binational Science FoundationBSF2005003 and the Israeli Anti-Drug Authority.
References (43)
- et al.
Co-expression of Fos immunoreactivity in protein kinase (PKC gamma)-positive neurones: quantitative analysis of a brain region involved in learning
Brain Res.
(1993) - et al.
Getting better all the time: improving preference scores reflect increases in the strength of filial imprinting
Anim. Behav.
(2000) - et al.
Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice
Neurotoxicology
(2008) - et al.
Effects of restricted lesions of the chick forebrain on the acquisition of filial preferences during imprinting
Brain Res.
(1981) - et al.
Alterations in PKCgamma in the mouse hippocampus after prenatal exposure to heroin: a link from cell signaling to behavioral outcome
Brain Res. Dev. Brain Res.
(2003) - et al.
Developmental toxicity and alteration of gene expression in zebrafish embryos exposed to PFOS
Toxicol. Appl. Pharmacol.
(2008) - et al.
Methodological considerations in neurobehavioral teratology
Pharmacol. Biochem. Behav.
(1996) - et al.
Neural grafting reverses prenatal drug-induced alterations in hippocampal PKC and related behavioral deficits
Brain Res. Dev. Brain Res.
(2000) - et al.
Differential distribution of protein kinase C (PKC alpha beta and PKC gamma) isoenzyme immunoreactivity in the chick brain
Brain Res.
(1995) - et al.
Alterations in hippocampal cholinergic receptors and hippocampal behaviors after early exposure to nicotine
Brain Res. Bull.
(1992)
Prenatal heroin exposure alters cholinergic receptor stimulated translocation and basal levels of the PKCbetaII and PKCgamma isoforms
Brain Res. Bull.
Differential expression of chicken hepatic genes responsive to PFOA and PFOS
Toxicology
Opiates inhibit neurogenesis in the adult rat hippocampus
Proc. Natl. Acad. Sci. U. S. A.
Classical conditioning induces long-term translocation of protein kinase C in rabbit hippocampal CA1 cells
Proc. Natl. Acad. Sci. U. S. A.
The characteristics and context of imprinting
Biol. Rev. Camb. Philos. Soc.
Nicotine therapy in adulthood reverses the synaptic and behavioral deficits elicited by prenatal exposure to phenobarbital.
Neuropsychopharmacology
Transplantation of neural progenitors enhances production of endogenous cells in the impaired brain
Mol. Psychiatry
Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000
Environ. Health Perspect.
Global distribution of perfluorooctane sulfonate in wildlife
Environ. Sci. Technol.
Sex-linked feathering of female hybrid chick embryos hormonally conditioned
Experientia
Cited by (43)
PFAS as emerging pollutants in the environment: A challenge with FAU type and silver-FAU exchanged zeolites for their removal from water
2022, Journal of Environmental Chemical EngineeringConcentrations and human exposure assessment of per and polyfluoroalkyl substances in farmed marine shellfish in South Africa
2021, ChemosphereCitation Excerpt :PFAS are known to bioaccumulate in the environment (Domingo et al., 2012; Groffen et al., 2018), and long-chain PFAS can biomagnify throughout the food chain, including humans. Several adverse human health effects, such as hepatotoxicity, immunotoxicity, neurobehavioural toxicity, developmental toxicity, lung toxicity, and weak carcinogenic and genotoxic potentials, have been reported for PFAS (Eriksen et al., 2011; Pinkas et al., 2010; Svihlikova et al., 2015). Although there are no official records on the production of PFAS in South Africa, a 2019 United Nations Environment Program (UNEP) report indicated that an estimated 74 720 kg of PFOS were exported to Malawi, Mauritius, Zambia, and Zimbabwe from South Africa in 2013 alone (UNEP, 2019).
Modeled prenatal exposure to per- and polyfluoroalkyl substances in association with child autism spectrum disorder: A case-control study
2020, Environmental ResearchCitation Excerpt :Maternal PFAS serum concentrations during pregnancy were weakly to moderately correlated with 3-year-old children's serum concentrations (Kingsley et al., 2018), whereas concurrent PFAS serum concentrations between child and mother from the same family were moderately correlated (Mondal et al., 2012; Wu et al., 2015). PFAS have been shown to have potential neurobehavioral toxicity in studies with laboratory animals (Mariussen, 2012; Johansson et al., 2008, 2009; Sobolewski et al., 2014; Onishchenko et al., 2011; Sato et al., 2009; Eggers Pedersen et al., 2015; Pinkas et al., 2010). In humans, the associations between exposures to PFAS and neurodevelopmental or behavioral problems are still inconclusive (Braun et al., 2014; Hoffman et al., 2010; Stein and Savitz, 2011; Fei and Olsen, 2011; Niu et al., 2019).
- ☆
Disclaimers: TAS has provided expert witness testimony in the past three years at the behest of the following law firms: The Calwell Practice (Charleston WV), Frost Brown Todd (Charleston WV), Snyder Weltchek & Snyder (Baltimore MD), Finnegan Henderson Farabow Garrett & Dunner (Washington DC), Frommer Lawrence Haug (Washington DC), Carter Law (Peoria IL), Corneille Law (Madison WI), Angelos Law (Baltimore MD), Kopff, Nardelli & Dopf (New York NY), and Gutglass Erickson Bonville & Larson (Madison WI).